Satsuki Kawasaki

Suggest Changes
Learn More
OBJECTIVE We investigated the effect of addition of alogliptin, while continuing the α-glucosidase inhibitor (αGI) administration at the same or reduced dose, or discontinuing the drug, on the(More)